Tuesday, October 03, 2006 2:17:42 PM
Now if the statuatory rate is 12% for example and you accrue at 8% you need to convince your auditors on why 8% is more approriate than 12%.
All in all this is one accounting issue they have handled very well. The actual shortfall is really nothing more than this years interest charges.
Now for what is really important I wonder how we did for Q3 since the price is down to a Buck and a couple pennies now.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM